Search Results - Lillian M. Smyth

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study

    Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from... by Lillian M. Smyth, Neil M. Iyengar, M. F. Chen, S. M. Popper, Sujata Patil, Carolyn Wasserheit-Lieblich, Daniel F. Argolo, Jasmeet Singh, Sarat Chandarlapaty, S. Sugarman, Elizabeth Comen, Pamela Drullinsky, Tiffany A. Traina, Tiffany A. Troso-Sandoval, José Baselga, Larry Norton, Clifford A. Hudis, Chau T. Dang

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and <i><scp>TERT</scp></i> promoter hotspot mutations and <i>TERT</i> gene amplification as likely drivers of progression

    Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and <i><scp>TERT</scp></i> promoter hotspot mutations and <i>TERT</i> gene amplificat... by Salvatore Piscuoglio, Charlotte K.Y. Ng, Melissa P. Murray, Kathleen A. Burke, Marcia Edelweiss, Felipe C. Geyer, Gabriel S. Macedo, Akiko Inagaki, Anastasios D. Papanastasiou, Luciano G. Martelotto, Caterina Marchiò, Raymond S. Lim, Rafael A Ioris, Pooja K Nahar, Ino de Bruijn, Lillian M. Smyth, Muzaffar Akram, Dara S. Ross, John H.J. Petrini, Larry Norton, David B. Solit, José Baselga, Edi Brogi, Marc Ladanyi, Britta Weigelt, Jorge S. Reis‐Filho

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with<i>AKT1</i>E17K-Mutant, ER-Positive Metastatic Breast Cancer

    Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with<i>AKT1</i>E17K-Mutant, ER-Positive Metastatic Breast Cancer by Lillian M. Smyth, Kenji Tamura, Mafalda Oliveira, Eva Ciruelos, Ingrid A. Mayer, Marie‐Paule Sablin, Laura Biganzoli, Helen J. Ambrose, Jack Ashton, Alan Barnicle, Des D. Cashell, Claire Corcoran, Elza C. de Bruin, Andrew Foxley, Joana Hauser, Justin P.O. Lindemann, Rhiannon Maudsley, Robert McEwen, Michele Moschetta, Martin Pass, Vicky Rowlands, Gaia Schiavon, Udai Banerji, Maurizio Scaltriti, Barry S. Taylor, Sarat Chandarlapaty, José Baselga, David M. Hyman

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Characteristics and Outcome of <i>AKT1</i>E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry

    Characteristics and Outcome of <i>AKT1</i>E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry by Lillian M. Smyth, Qin Zhou, Bastien Nguyen, Celeste Yu, Eva M. Lepisto, Mónica Arnedos, Michael J. Hasset, Michele L. Lenoue-Newton, Natalie Blauvelt, Semih Doğan, Christine Micheel, Chetna Wathoo, Hugo M. Horlings, Jan Hudeček, Benjamin Groß, Ritika Kundra, Shawn M. Sweeney, Jianjiong Gao, Nikolaus Schultz, Andrew Zarski, Stuart M. Gardos, Jocelyn Lee, Seth Sheffler‐Collins, Ben Ho Park, Charles L. Sawyers, Fabrice André, Mia Levy, Funda Meric‐Bernstam, Philippe L. Bédard, Alexia Iasonos, Deborah Schrag, David M. Hyman

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations

    AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations by David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue, Shannon N. Westin, Philippe L. Bédard, Emma Dean, Hideaki Bando, Anthony B. El-Khoueiry, José Alejandro Pérez Fidalgo, Alain C. Mita, Jan H.M. Schellens, Matthew T. Chang, Jonathan Reichel, Nancy Bouvier, S. Duygu Selçuklu, Tara E. Soumerai, Jean Torrisi, Joseph P. Erinjeri, Helen Ambrose, J. Carl Barrett, Brian Dougherty, Andrew Foxley, Justin P.O. Lindemann, Robert McEwen, Martin Pass, Gaia Schiavon, Michael F. Berger, Sarat Chandarlapaty, David B. Solit, Udai Banerji, José Baselga, Barry S. Taylor

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers by Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio‐Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    HER kinase inhibition in patients with HER2- and HER3-mutant cancers

    HER kinase inhibition in patients with HER2- and HER3-mutant cancers by David M. Hyman, Sarina A. Piha‐Paul, Helen Won, Jordi Rodón, Cristina Saura, Geoffrey I. Shapiro, Dejan Juric, David I. Quinn, Víctor Moreno, Bernard Doger, Ingrid A. Mayer, Valentina Boni, Emiliano Calvo, Sherene Loi, A. Craig Lockhart, Joseph P. Erinjeri, Maurizio Scaltriti, Gary A. Ulaner, Juber Patel, Jiabin Tang, Hannah Beer, S. Duygu Selçuklu, Aphrothiti J. Hanrahan, Nancy Bouvier, Myra Melcer, Rajmohan Murali, Alison M. Schram, Lillian M. Smyth, Komal Jhaveri, Bob T. Li, Alexander Drilon, James J. Harding, Gopa Iyer, Barry S. Taylor, Michael F. Berger, Richard E. Cutler, Feng Xu, Anna Butturini, Lisa D. Eli, Grace Mann, Cynthia Farrell, Alshad S. Lalani, Richard Bryce, Carlos L. Arteaga, Funda Meric‐Bernstam, José Baselga, David B. Solit

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Efficacy and Determinants of Response to HER Kinase Inhibition in<i>HER2</i>-Mutant Metastatic Breast Cancer

    Efficacy and Determinants of Response to HER Kinase Inhibition in<i>HER2</i>-Mutant Metastatic Breast Cancer by Lillian M. Smyth, Sarina A. Piha‐Paul, Helen Won, Alison M. Schram, Cristina Saura, Sherene Loi, Janice Lu, Geoffrey I. Shapiro, Dejan Juric, Ingrid A. Mayer, Carlos L. Arteaga, Macarena I. de la Fuente, Adam M. Brufksy, Iben Spanggaard, Morten Mau‐Sørensen, Mónica Arnedos, Víctor Moreno, Valentina Boni, Joohyuk Sohn, Lee S. Schwartzberg, Xavier González, Andrés Cervantes, François‐Clément Bidard, Alexander N. Gorelick, Richard B. Lanman, Rebecca J. Nagy, Gary A. Ulaner, Sarat Chandarlapaty, Komal Jhaveri, Elena I. Gavrila, Catherine Zimel, S. Duygu Selçuklu, Myra Melcer, Aliaksandra Samoila, Yanyan Cai, Maurizio Scaltriti, Grace Mann, Feng Xu, Lisa D. Eli, Melanie Dujka, Alshad S. Lalani, Richard Bryce, José Baselga, Barry S. Taylor, David B. Solit, Funda Meric‐Bernstam, David M. Hyman

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

    Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS by A. Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu, Fanli Meng, Mohammad Mahfuzul Haque, Justyna Sadowska, Brian J. Murphy, Tessara Baldi, Ian Johnson, Ryan Ptashkin, Maysun Hasan, Preethi Srinivasan, Anoop Balakrishnan Rema, Ivelise Rijo, Aaron Agarunov, Helen Won, D. S. Perera, David Brown, Aliaksandra Samoila, Xiaohong Jing, Erika Gedvilaite, Julie L. Yang, Dennis Stephens, Jenna-Marie Dix, Nicole DeGroat, Khédoudja Nafa, Aijazuddin Syed, Alan Li, Emily S. Lebow, Anita S. Bowman, Donna C. Ferguson, Ying Liu, Douglas A. Mata, Rohit Sharma, Soo‐Ryum Yang, Tejus Bale, Jamal Benhamida, Jason C. Chang, Snjezana Doğan, Meera Hameed, Jaclyn F. Hechtman, Christine Moung, Dara S. Ross, Efsevia Vakiani, Chad Vanderbilt, JinJuan Yao, Pedram Razavi, Lillian M. Smyth, Sarat Chandarlapaty, Gopa Iyer, Wassim Abida, James J. Harding, Benjamin A. Krantz, Eileen M. O’Reilly, Helena A. Yu, Bob T. Li, Charles M. Rudin, Luis A. Díaz, David B. Solit, Maria E. Arcila, Marc Ladanyi, Brian Houck‐Loomis, Dana W.Y. Tsui, Michael F. Berger, Ahmet Zehir, Ryma Benayed

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: